Stay updated with breaking news from ஹாஃப்கைன் உயிர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
No discrimination over allocation of drugs to treat Mucormycosis: Centre to Bombay HC | India News indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Haffkine Bio-Pharmaceutical Corporation Limited (HBPCL), a Maharashtra government undertaking, is preparing for mass production of Covaxin and will have capacity to produce over 22 crore doses of the COVID-19 vaccine every year once the requisite facilities are in place. The Department of Biotechnology has given permission to HBPCL for producing Covaxin under Mission Covid Suraksha. Covaxin has been developed by Bharat Biotech in collaboration with ICMR. Sandeep Rathod, Managing Director of HBPCL, told ANI that formalities of technology transfer from Bharat Biotech are being completed. We are completing formalities of technology transfer and they will be completed soon. We have signed the confidentiality clause with Bharat Biotech and the finalisation of MoU is under process, he said. ....
The Department of Biotechnology has given permission to HBPCL for producing Covaxin under Mission Covid Suraksha. Covaxin has been developed by Bharat Biotech in collaboration with ICMR. ....
While government-owned pharma companies are ailing from years of neglect, some have rolled up their sleeves and joined Indias uphill battle against Covid, with plans to manufacture drugs that are used for treatment of Covid-19 patients or to produce vaccines that can shield people from the dreaded SARS-CoV-2 virus. ....